A new study has found that it would be cost-effective to treat 48-67 percent of all adults aged 40-75 in the US with cholesterol-lowering statins. By expanding the current recommended treatment guidelines and boosting the percentage of adults taking statins, an additional 161,560 cardiovascular-related events could be averted, according to the researchers.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1HuzQZB
No comments:
Post a Comment